Moderna
MRNA
$137.91
Share price
5.95%
Change (1 day)
-14.54%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.
Market capitalization of Moderna (MRNA)
Market cap: $54.85 Billion
As of May 2022 Moderna has a market cap of $54.85 Billion. This makes Moderna the world's 268th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Market cap history of Moderna from 2018 to 2022
| Year | Market cap | Change |
|---|---|---|
| 2022 | $54.85 B | -46.73% |
| 2021 | $102.97 B | 149.1% |
| 2020 | $41.33 B | 528.01% |
| 2019 | $6.58 B | 31.11% |
| 2018 | $5.02 B |
End of Day market cap according to different sources
On May 15th, 2022 the market cap of Moderna was reported to be:
$54.85 Billion
$54.85 Billion
$54.85 Billion
$54.85 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $465.36 B | 748.35% | 🇺🇸 USA |
 Novartis NVS | $190.43 B | 247.15% | 🇨🇭 Switzerland |
 Merck MRK | $228.62 B | 316.79% | 🇺🇸 USA |
 Regulus Therapeutics RGLS | $0.03 B | -99.94% | 🇺🇸 USA |
 Dicerna Pharmaceuticals DRNA | $2.97 B | -94.57% | 🇺🇸 USA |
 Athersys ATHX | $0.14 B | -99.73% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $15.27 B | -72.15% | 🇺🇸 USA |
 Arrowhead Pharmaceuticals
ARWR | $3.34 B | -93.90% | 🇺🇸 USA |